Form D · Biotechnology
Glycosan BioSystems, Inc.
Salt Lake City, UT · CIK 0001402008
Offering snapshot reported May 13, 2010 · SEC filing
- Reported sold
- $625K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 3, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2010 | Initial | $625,000 | No comparison | 3 | SEC filing |
| Jul 30, 2009 | Initial | $325,000 | No comparison | 6 | SEC filing |
| Nov 24, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 7, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-141997
Source: Form D, filed May 13, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Glenn D Prestwich | Director, Executive |
| William P Tew | Director, Executive |
| Fenner, Jr. Weller | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
675 Arapeen Drive Suite 302
Salt Lake City, UT, 84108
Salt Lake City, UT, 84108